A proof-of-principle study of epigenetic therapy with hydralazine and magnesium valproate plus doxorubicin cyclophosphamide as neoadjuvant therapy for locally advanced breast cancerReport as inadecuate




A proof-of-principle study of epigenetic therapy with hydralazine and magnesium valproate plus doxorubicin cyclophosphamide as neoadjuvant therapy for locally advanced breast cancer - Download this document for free, or read online. Document in PDF available to download.

BMC Cancer

, 7:A23

First Online: 05 February 2007 Download fulltext PDF



Author: Claudia Arce - Carlos Perez-Plasencia - Aurora Gonzalez-Fierro - Erik de la Cruz-Hernandez - Alma Revilla-Vazquez - Alma Cha

Source: https://link.springer.com/



DOWNLOAD PDF




Related documents